Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

As if AIDS Drug Assistance Program (ADAP) directors and other people monitoring the costs of providing HIV drugs to the uninsured weren’t worried enough, they have a new potential problem to discuss: How would t he states and ADAP programs handle a large influx of new HIV and AIDS patients if the Centers for Disease Control and Prevention (CDC) succeeds in significantly increasing HIV testing rates?

Rapid tests could mean trouble for ADAPS